Senior insider sale
VP of Regulatory Affairs at IMMUNOGEN, INC. — senior position signals high conviction
$19.62M
854.57K shares
WINGROVE THERESA plans to sell 854.57K shares of IMMUNOGEN, INC. valued at approximately $19.62M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of employee stock options
Broker assisted cashless exercise
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/16/2024 | Exercise of employee stock options Broker assisted cashless exercise | 187.67K | — |
| Total | 187.67K | ||
Completed
Units to sell
117.44K
Market value
$3.45M
Units to sell
164.42K
Market value
$4.76M
Units to sell
6.79K
Market value
$113.2K
Units to sell
166.72K
Market value
$2.64M
Units to sell
19.52K
Market value
$325.1K
Units to sell
192K
Market value
$2.76M
Planned — Approximate Date
Units to sell
187.67K
Market value
$5.56M
Units
854.57K
Value
$19.62M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/15/2023 | 117.44K | $3.45M | — | Completed |
11/30/2023 | 164.42K | $4.76M | — | Completed |
11/29/2023 | 6.79K | $113.2K | — | Completed |
11/15/2023 | 166.72K | $2.64M | — | Completed |
11/7/2023 | 19.52K | $325.1K | — | Completed |
10/16/2023 | 192K | $2.76M | — | Completed |
| Planned — Approximate Date | ||||
1/16/2024 | 187.67K | $5.56M | NASDAQ | Planned |
| Total | 854.57K | $19.62M | ||